Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Actin-related protein 3B (ACTR3B) is a member of the actin-related protein (ARP) family, sharing 35–55% identity with conventional actin[1][2][3][4][5][8]. It is an ATP-binding component of the Arp2/3 complex, which regulates actin polymerization and formation of branched actin filament networks[1][2][4][8]. The protein is involved in organizing the actin cytoskeleton, promoting cell shape changes, and potentially modulating cell motility[1][2][8]. Multiple transcript variants and protein isoforms exist due to alternative splicing[1][2]. ACTR3B may play a role in tumor biology, including possible reduction of metastatic potential[1][2][3]. There is currently no evidence identifying ACTR3B as a direct therapeutic target or of clinical drugs targeting it[1][2][5][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Actin-related protein 3B (ACTR3B).